行情

SRNE

SRNE

Sorrento Thera
NASDAQ

实时行情|Nasdaq Last Sale

2.280
-0.005
0.00%
盘后: 2.280 0 0.00% 16:45 09/20 EDT
开盘
2.280
昨收
2.280
最高
2.440
最低
2.250
成交量
165.38万
成交额
--
52周最高
6.50
52周最低
1.800
市值
2.99亿
市盈率(TTM)
-1.0554
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

SRNE 新闻

  • 欧佩克8月没减产? 原油需求增速继续遭下调
  • 新浪财经综合.09/11 10:32
  • 贝索斯等50多位CEO签联名信 呼吁国会制定数据隐私法
  • 新浪科技.09/11 10:20
  • Louis Capital:港交所并购伦交所要约不太可能成功
  • 新浪财经.09/11 10:12
  • 港交所提议与伦证所合并 对后者估值高达366亿美元
  • 新浪财经综合.09/11 09:51

更多

所属板块

生物技术和医学研究
+0.62%
制药与医学研究
+0.95%

热门股票

名称
价格
涨跌幅

SRNE 简况

Sorrento Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, acquisition, development and commercialization of drug therapeutics. Its primary therapeutic focus is oncology, including the treatment of chronic cancer pain. It is also developing therapeutic products for other indications, including immunology and infectious diseases. Its products in the pipeline include Chimeric Antigen Receptor-T Cell (CAR-T) programs, resiniferatoxin (RTX), and biosimilar/biobetter antibodies clinical development programs. Its pipeline also includes preclinical fully human therapeutic monoclonal antibodies (mAbs), including biosimilars/biobetters, fully human anti-PD-L1 and anti-PD-1 checkpoint inhibitors derived from its G-MAB library platform, antibody drug conjugates (ADCs), bispecific antibodies (BsAbs), as well as CAR-T and Chimeric Antigen Receptor Natural Killer (NK) cells (CAR. NK) for adoptive cellular immunotherapy.
展开

Webull提供Sorrento Therapeutics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。